載入...
Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics
Many pathogens use the same immune evasion mechanisms as cancer cells. Patients with chronic infections have elevated levels of checkpoint receptors (e.g., programed cell death 1, PD1) on T cells. Monoclonal antibody (mAb)-based inhibitors to checkpoint receptors have also been shown to enhance T-ce...
Na minha lista:
| 發表在: | Front Immunol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7068811/ https://ncbi.nlm.nih.gov/pubmed/32210956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.00264 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|